No 10Y consistency score for revenue — its stored periods are half-year spaced, so quarter-over-same-quarter consistency is not computed.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 6 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Niki BioSolutions, Inc. (NIKI) stock was $4.96 as of Oct 6, 2026, 4:00 PM EDT, up 4.89% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -97.9% · 3-year avg -71.8%/yr · 5-year avg -71.4%/yr
Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets.
Biotechnology · Princeton, NJ
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-4.20
vs Estimate
N/A
Revenue
$0.00
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1NIKI | $403,887 | $4.96 | +4.89% | -97.86% | -71.40% | N/A | N/A |
| 2VRAX | $378,849 | $2.03 | -15.42% | -84.29% | N/A | N/A | vs NIKI |
| 3XRTX | $481,786 | $1.73 | +1.76% | -57.33% | -63.52% | N/A | vs NIKI |
| 4VIVS | $518,606 | $0.20 | -2.18% | -93.85% | N/A | N/A | vs NIKI |
| 5HCWB | $545,796 | $1.57 | -4.27% | -93.15% | -69.71% | N/A | vs NIKI |
| 6SPRC | $250,443 | $4.33 | -0.69% | -89.69% | -82.56% | N/A | vs NIKI |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$4.96
High
N/A
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $31.00 | $31.00 | $31.00 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $106.80M | $106.80M | $106.80M | 1 |
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
